Related Experiment Video
Updated: Aug 29, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
A review of pharmacologic interventions to prevent contrast-induced nephropathy
1David Geffen School of Medicine at UCLA, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Insights
Preventing contrast-induced nephropathy (CIN) is crucial. Research explores various strategies, but understanding CIN pathophysiology is key to effective prevention for clinicians.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) poses significant clinical challenges.
- CIN prevention is a major focus in cardiovascular and nephrology research.
- Understanding CIN pathophysiology is essential for developing effective prevention strategies.
Purpose of the Study:
- To review contemporary clinical trials for contrast-induced nephropathy (CIN) prevention.
- To aid clinicians in developing data-driven approaches to CIN prevention.
- To highlight the ongoing research efforts and challenges in CIN prevention.
Main Methods:
- Review of major medical journals and cardiovascular conference proceedings.
- Analysis of clinical trials investigating different CIN prevention theories.
- Evaluation of strategies based on ischemia, free radical formation, and direct toxicity.
Main Results:
- Ongoing development of CIN prevention strategies.
- Efforts are hampered by incomplete understanding of CIN pathophysiology.
- Multiple theories, including ischemia, free radicals, and direct toxicity, guide research.
Conclusions:
- A comprehensive review of CIN prevention trials is provided.
- Clinicians can use this review to inform their CIN prevention strategies.
- Further research is needed to fully elucidate CIN pathophysiology.
Abstract:
The serious clinical implications of contrast-induced nephropathy (CIN) have focused researchers on prevention strategies. Increased coverage of CIN in major medical journals and at major cardiovascular meetings, including the Transcatheter Cardiovascular Therapeutics (sponsored by the Cardiovascular Research Foundation), American College of Cardiology, and American Heart Association conferences, highlight this concern. Development of CIN prevention strategies is ongoing, but efforts have been hampered by an incomplete understanding of CIN pathophysiology. The most popular theories include contrast-induced renal tubular ischemia, free radical formation, and a direct tubular toxic effect. Proponents of an ischemia model direct clinical trials evaluating the efficacy of a variety of vasodilators, while those who favor a free radical or direct toxicity theory study antioxidants and free radical scavengers, or a variety of contrast agents varying in osmolality, ionicity, and viscosity. A comprehensive review of the more important and contemporary CIN prevention trials is provided to assist the cardiologist, radiologist, or nephrologist in developing his or her own data-driven approach to CIN prevention.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury VI: Nursing Management
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Acute Kidney Injury V: Interprofessional Care
